Selected research
Market Structure
Global Taurine and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Taurine and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Taurine and Derivatives include Taisho Pharmaceutical, Yuanyang Pharmaceutical, Jiangyin Huachang, Yongan Pharmaceutical, Zhejiang NHU Co., Ltd and Grand Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Taurine and Derivatives output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Taurine and Derivatives by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Taurine and Derivatives market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Taurine and Derivatives and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Taurine and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taurine and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.
Taurine and Derivatives Segment by Company
Taisho Pharmaceutical
Yuanyang Pharmaceutical
Jiangyin Huachang
Yongan Pharmaceutical
Zhejiang NHU Co., Ltd
Grand Pharma
Taurine and Derivatives Segment by Type
Taurine
Taurine Derivatives
Taurine and Derivatives Segment by Application
Beverages
Pet Food
Health Products
Others
Taurine and Derivatives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taurine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Taurine and Derivatives market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Taurine and Derivatives industry.
Chapter 3: Detailed analysis of Taurine and Derivatives market competition landscape. Including Taurine and Derivatives manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Taurine and Derivatives by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Taurine and Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Taurine
- Taurine Derivatives
Applications
- Beverages
- Pet Food
- Health Products
- Others
Companies covered
- Taisho Pharmaceutical
- Yuanyang Pharmaceutical
- Jiangyin Huachang
- Yongan Pharmaceutical
- Zhejiang NHU Co., Ltd
- Grand Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Taurine and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Taurine and Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Taurine and Derivatives Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Taurine and Derivatives Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Taurine and Derivatives Market Dynamics
- 2.1 Taurine and Derivatives Industry Trends
- 2.2 Taurine and Derivatives Industry Drivers
- 2.3 Taurine and Derivatives Industry Opportunities and Challenges
- 2.4 Taurine and Derivatives Industry Restraints
3 Taurine and Derivatives Market by Manufacturers
- 3.1 Global Taurine and Derivatives Production Value by Manufacturers (2021-2026)
- 3.2 Global Taurine and Derivatives Production by Manufacturers (2021-2026)
- 3.3 Global Taurine and Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Taurine and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taurine and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Taurine and Derivatives Manufacturers, Product Type & Application
- 3.7 Global Taurine and Derivatives Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Taurine and Derivatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Taurine and Derivatives Players Market Share by Production Value in 2025
- 3.8.3 2025 Taurine and Derivatives Tier 1, Tier 2, and Tier 3
4 Taurine and Derivatives Market by Type
- 4.1 Taurine and Derivatives Type Introduction
- 4.1.1 Taurine
- 4.1.2 Taurine Derivatives
- 4.2 Global Taurine and Derivatives Production by Type
- 4.2.1 Global Taurine and Derivatives Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Taurine and Derivatives Production by Type (2021-2032)
- 4.2.3 Global Taurine and Derivatives Production Market Share by Type (2021-2032)
- 4.3 Global Taurine and Derivatives Production Value by Type
- 4.3.1 Global Taurine and Derivatives Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Taurine and Derivatives Production Value by Type (2021-2032)
- 4.3.3 Global Taurine and Derivatives Production Value Market Share by Type (2021-2032)
5 Taurine and Derivatives Market by Application
- 5.1 Taurine and Derivatives Application Introduction
- 5.1.1 Beverages
- 5.1.2 Pet Food
- 5.1.3 Health Products
- 5.1.4 Others
- 5.2 Global Taurine and Derivatives Production by Application
- 5.2.1 Global Taurine and Derivatives Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Taurine and Derivatives Production by Application (2021-2032)
- 5.2.3 Global Taurine and Derivatives Production Market Share by Application (2021-2032)
- 5.3 Global Taurine and Derivatives Production Value by Application
- 5.3.1 Global Taurine and Derivatives Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Taurine and Derivatives Production Value by Application (2021-2032)
- 5.3.3 Global Taurine and Derivatives Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Taisho Pharmaceutical
- 6.1.1 Taisho Pharmaceutical Company Information
- 6.1.2 Taisho Pharmaceutical Business Overview
- 6.1.3 Taisho Pharmaceutical Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.1.4 Taisho Pharmaceutical Taurine and Derivatives Product Portfolio
- 6.1.5 Taisho Pharmaceutical Recent Developments
- 6.2 Yuanyang Pharmaceutical
- 6.2.1 Yuanyang Pharmaceutical Company Information
- 6.2.2 Yuanyang Pharmaceutical Business Overview
- 6.2.3 Yuanyang Pharmaceutical Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.2.4 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio
- 6.2.5 Yuanyang Pharmaceutical Recent Developments
- 6.3 Jiangyin Huachang
- 6.3.1 Jiangyin Huachang Company Information
- 6.3.2 Jiangyin Huachang Business Overview
- 6.3.3 Jiangyin Huachang Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.3.4 Jiangyin Huachang Taurine and Derivatives Product Portfolio
- 6.3.5 Jiangyin Huachang Recent Developments
- 6.4 Yongan Pharmaceutical
- 6.4.1 Yongan Pharmaceutical Company Information
- 6.4.2 Yongan Pharmaceutical Business Overview
- 6.4.3 Yongan Pharmaceutical Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.4.4 Yongan Pharmaceutical Taurine and Derivatives Product Portfolio
- 6.4.5 Yongan Pharmaceutical Recent Developments
- 6.5 Zhejiang NHU Co., Ltd
- 6.5.1 Zhejiang NHU Co., Ltd Company Information
- 6.5.2 Zhejiang NHU Co., Ltd Business Overview
- 6.5.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.5.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio
- 6.5.5 Zhejiang NHU Co., Ltd Recent Developments
- 6.6 Grand Pharma
- 6.6.1 Grand Pharma Company Information
- 6.6.2 Grand Pharma Business Overview
- 6.6.3 Grand Pharma Taurine and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.6.4 Grand Pharma Taurine and Derivatives Product Portfolio
- 6.6.5 Grand Pharma Recent Developments
7 Global Taurine and Derivatives Production by Region
- 7.1 Global Taurine and Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Taurine and Derivatives Production by Region (2021-2032)
- 7.2.1 Global Taurine and Derivatives Production by Region (2021-2026)
- 7.2.2 Global Taurine and Derivatives Production Forecast by Region (2027-2032)
- 7.3 Global Taurine and Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Taurine and Derivatives Production Value by Region (2021-2032)
- 7.4.1 Global Taurine and Derivatives Production Value by Region (2021-2026)
- 7.4.2 Global Taurine and Derivatives Production Value by Region (2027-2032)
- 7.5 Global Taurine and Derivatives Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Taurine and Derivatives Production Value (2021-2032)
- 7.6.2 Europe Taurine and Derivatives Production Value (2021-2032)
- 7.6.3 Asia-Pacific Taurine and Derivatives Production Value (2021-2032)
- 7.6.4 South America Taurine and Derivatives Production Value (2021-2032)
- 7.6.5 Middle East & Africa Taurine and Derivatives Production Value (2021-2032)
8 Global Taurine and Derivatives Consumption by Region
- 8.1 Global Taurine and Derivatives Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Taurine and Derivatives Consumption by Region (2021-2032)
- 8.2.1 Global Taurine and Derivatives Consumption by Region (2021-2026)
- 8.2.2 Global Taurine and Derivatives Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Taurine and Derivatives Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Taurine and Derivatives Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Taurine and Derivatives Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Taurine and Derivatives Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Taurine and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Taurine and Derivatives Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Taurine and Derivatives Value Chain Analysis
- 9.1.1 Taurine and Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Taurine and Derivatives Production Mode & Process
- 9.2 Taurine and Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Taurine and Derivatives Distributors
- 9.2.3 Taurine and Derivatives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst